Loading
Latest filing published 09 Jan 2017 for Kalytera Therapeutics, Inc..
No signal scores available.
Seth Yakatan appears in our data through filings on Kalytera Therapeutics, Inc. shares, published by SEDI. The record holds 2 filings, all for trades on 30 December 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 9 January 2017: a transaction, in Kalytera Therapeutics, Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations